Pfizer Expects To Seek US Approval For COVID-19 Vaccine For Children Aged 6 Months To 5 Years In November
Pfizer Inc (NYSE: PFE) expects to apply for U.S. authorization of its COVID-19 vaccine for children aged six months and five years in November, the Financial Times reported.